HeartSciences wins FDA 510(k) clearance for MyoVista wavECG device

Bitget2026/10/06 12:32

HeartSciences won FDA 510(k) clearance (K260005) for its MyoVista wavECG device as a 12-lead resting electrocardiograph. Clearance covers ECG acquisition and interpretation for adult, pediatric patients in hospitals, healthcare facilities. Authorization excludes the AI-ECG algorithm; HeartSciences has no timeline to commercialize the device. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Heartsciences Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610060830PRIMZONEFULLFEED9840283) on October 06, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

Tekedia Capital flags signs global bond sell-off is losing momentum

Bitget•2026/10/10 12:22

Dogecoin ETF to Shut as Bitwise CEO Flags Weak Demand

CoinCryptoNewz•2026/10/10 10:57

TD Cowen lowers UnitedHealth target price to $402

格隆汇•2026/10/10 09:31

Specter questions the issuance and refund arrangements of Serpin token

AiCoin•2026/10/10 09:29